Promoter Usage for Insulin-like Growth Factor-II in Cancerous and Benign Human Breast, Prostate, and Bladder Tissues, and Confirmation of a 10th Exon

By Mineo R.   Fichera E.   Liang S-J.   Fujita-Yamaguchi Y.  

Biochemical and Biophysical Research Communications, Vol. 268, Iss. 3, 2000-02 ,pp. : 886-892

Elsevier

Access to resources Recommend Favorite

Selenium concentration in the prostate

By Arnold Wilfred   Thrasher J.  

Biological Trace Element Research, Vol. 91, Iss. 3, 2003-03 ,pp. : 277-280

Humana Press, Inc

Access to resources Recommend Favorite

Carbohydrate structure and differential binding of prostate specific antigen to Maackia amurensis lectin between prostate cancer and benign prostate hypertrophy

By Ohyama Chikara  

Glycobiology, Vol. 14, Iss. 8, 2004-08 ,pp. : 671-679

Oxford University Press

Access to resources Recommend Favorite

Selenium/cadmium ratios in human prostates: Indicators of prostate cancer risk of smokers and nonsmokers, and relevance to the cancer protective effects of selenium

By Drasch Gustav   Schöpfer Jutta   Schrauzer Gerhard  

Biological Trace Element Research, Vol. 103, Iss. 2, 2005-02 ,pp. : 103-107

Humana Press, Inc

Access to resources Recommend Favorite

Core fucosylation and 2-3 sialylation in serum N -glycome is significantly increased in prostate cancer comparing to benign prostate hyperplasia

By Saldova Radka   Fan Yue   Fitzpatrick John M   Watson R William G   Rudd Pauline M  

Glycobiology, Vol. 21, Iss. 2, 2011-02 ,pp. : 195-205

Oxford University Press

Access to resources Recommend Favorite